GSK 2193874 - 10mg
Membrane Transporter/Ion Channel : TRP Channel , store at -20°C
Advanced TRPV4 Antagonist a highly selective and potent transient receptor potential vanilloid 4 (TRPV4) antagonist, is designed for advanced research applications in cellular and molecular biology. This compound is instrumental in exploring TRPV4-mediated physiological and pathological processes, including inflammation, nociception, cardiovascular function, and respiratory conditions.
Advanced TRPV4 Antagonist a highly selective and potent transient receptor potential vanilloid 4 (TRPV4) antagonist, is designed for advanced research applications in cellular and molecular biology. This compound is instrumental in exploring TRPV4-mediated physiological and pathological processes, including inflammation, nociception, cardiovascular function, and respiratory conditions.
Ce contenu sera partagé sur toutes les pages produits.
Key Features:
- Selective TRPV4 Inhibition: Precisely targets the TRPV4 ion channel with minimal off-target effects.
- High Potency: Effective at low concentrations, ensuring reliable experimental results.
- Research-Grade Purity: Manufactured to meet the highest standards for reproducibility and accuracy.
- Versatile Applications: Suitable for in vitro and in vivo studies across various biological models.
Applications in Research:
- Investigating the role of TRPV4 in pain signaling and sensory neuron function.
- Exploring TRPV4's involvement in cardiovascular and pulmonary diseases.
- Evaluating TRPV4-associated pathways in inflammation and edema.
- Developing therapeutic interventions for TRPV4-related disorders.
Molecular Formula: C₁₉H₁₆Cl₃N₃O₂
GSK 2193874 is an invaluable tool for researchers seeking to advance their understanding of TRPV4's role in human physiology and pathology. Optimize your experiments and drive innovation with this state-of-the-art TRPV4 antagonist.